TNFα News and Research

RSS
Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

New biomarkers can predict risk of kidney failure in patients with diabetes

New biomarkers can predict risk of kidney failure in patients with diabetes

Scientists discover mechanism by which TNFα stimulates tumor formation

Scientists discover mechanism by which TNFα stimulates tumor formation

Study: Omega-3 supplements can decrease inflammation, anxiety

Study: Omega-3 supplements can decrease inflammation, anxiety

Colonoscopic FMT effective in treating IBD, C.difficile-associated diarrhea

Colonoscopic FMT effective in treating IBD, C.difficile-associated diarrhea

Short-term glucocorticoid treatment may prevent osteoarthritis after joint injury

Short-term glucocorticoid treatment may prevent osteoarthritis after joint injury

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Study investigates effectiveness of potential treatment for Non-alcoholic steatohepatitis

Study investigates effectiveness of potential treatment for Non-alcoholic steatohepatitis

Neovacs announces initiation of a Phase IIa clinical study of TNFα Kinoid immunotherapy

Neovacs announces initiation of a Phase IIa clinical study of TNFα Kinoid immunotherapy

Mayo study reveals infliximab reduces the need for colectomy

Mayo study reveals infliximab reduces the need for colectomy

Signaling molecules have different effects on key inhibitory protein

Signaling molecules have different effects on key inhibitory protein

Alcoholism may be dependent on IL-1 polymorphisms: Study

Alcoholism may be dependent on IL-1 polymorphisms: Study

A new slow-release hydrogen sulfide donating molecule may hold the key to the development of new anti-inflammatory drugs

A new slow-release hydrogen sulfide donating molecule may hold the key to the development of new anti-inflammatory drugs